ArticleFrontiers in oncology2021

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study.

Saeka Egami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.